Histone cluster 1 H3B Inhibitors
Chemical inhibitors of Histone cluster 1 H3B function by disrupting the normal acetylation-deacetylation balance that is crucial for maintaining the compact structure of chromatin. Compounds such as Trichostatin A, Vorinostat (also known as SAHA), and Panobinostat are known to inhibit histone deacetylases (HDACs), which leads to an increase in the acetylation levels of histone proteins. The hyperacetylation of Histone cluster 1 H3B, induced by these inhibitors, results in a more relaxed chromatin structure. This relaxed state interferes with the ability of the histone to facilitate the tight packing of DNA, which is a key component of its functional role in the cell. Enhanced acetylation levels prevent Histone cluster 1 H3B from effectively maintaining chromatin architecture, which is essential for the regulation of gene expression and the stability of the genome.
Other inhibitors, such as Mocetinostat, Entinostat, and Romidepsin, also target HDACs but may differ in their selectivity and mode of inhibition. These inhibitors contribute to the accumulation of acetylated Histone cluster 1 H3B, further reinforcing the disruption of chromatin's compact structure. Belinostat and Chidamide, by similar mechanisms, cause changes in the acetylation status of Histone cluster 1 H3B, leading to alterations in the chromatin landscape that inhibits its functional role. Additionally, Valproic acid, while not primarily an HDAC inhibitor, can increase Histone cluster 1 H3B acetylation, impacting its capacity to participate in chromatin compaction and control over gene expression. Givinostat and CUDC-101 round out the list of HDAC inhibitors that contribute to the elevation of acetylated Histone cluster 1 H3B, thereby altering its structural role in chromatin remodeling and gene expression regulation. These chemical inhibitors collectively facilitate the maintenance of a state where Histone cluster 1 H3B is unable to perform its crucial role in the structural organization of chromatin.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases (HDACs). By inhibiting HDAC activity, this compound increases the acetylation of histone proteins, including Histone cluster 1 H3B. Hyperacetylation of histones can disrupt chromatin structure and inhibit the transcription of certain genes, as well as affect DNA repair and replication processes, leading to the functional inhibition of the Histone cluster 1 H3B protein. | ||||||
Mocetinostat | 726169-73-9 | sc-364539 sc-364539B sc-364539A | 5 mg 10 mg 50 mg | $214.00 $247.00 $1463.00 | 2 | |
Mocetinostat is another HDAC inhibitor that, by blocking the deacetylation process, causes increased acetylation levels of histones such as Histone cluster 1 H3B. This hyperacetylation interferes with the histone's ability to package DNA tightly, thereby inhibiting the functional role of Histone cluster 1 H3B in maintaining chromatin structure and controlling gene expression. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a potent HDAC inhibitor that leads to the accumulation of acetylated histones, including Histone cluster 1 H3B. The accumulation of acetylated histones disrupts the normal deacetylation mechanisms necessary for the compact chromatin structure, thus inhibiting the functional role of Histone cluster 1 H3B in the regulation of gene expression and chromatin dynamics. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, an HDAC inhibitor, increases the levels of acetylated histones, such as Histone cluster 1 H3B, resulting in an open chromatin structure and subsequent inhibition of its function. This can interfere with DNA replication and repair mechanisms, as well as with the binding of transcription factors, thereby functionally inhibiting Histone cluster 1 H3B. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
Entinostat selectively inhibits class I HDACs, leading to the hyperacetylation of specific histones including Histone cluster 1 H3B. This hyperacetylation can disrupt the chromatin architecture and subsequently inhibit the functional roles of Histone cluster 1 H3B in DNA compaction and gene regulation. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a cyclic peptide HDAC inhibitor that increases acetylation levels of histones like Histone cluster 1 H3B. Enhanced acetylation can inhibit the ability of Histone cluster 1 H3B to interact properly with DNA and other histone proteins, thereby inhibiting its function in chromatin remodeling and gene expression. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat is an HDAC inhibitor that causes the accumulation of acetylated Histone cluster 1 H3B among other histones, leading to a more open chromatin structure and inhibition of the normal function of this histone in DNA packaging and gene regulation. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid, while primarily used for other indications, also acts as an HDAC inhibitor, leading to the hyperacetylation of histones such as Histone cluster 1 H3B. This can disrupt the chromatin structure and inhibit the ability of Histone cluster 1 H3B to function in gene regulation and DNA repair. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
Givinostat is an HDAC inhibitor that increases the acetylation level of histones including Histone cluster 1 H3B, disrupting the tight packing of DNA and inhibiting the structural role of Histone cluster 1 H3B in chromatin remodeling and control of gene expression. | ||||||
Chidamide | 743420-02-2 | sc-364462 sc-364462A sc-364462B | 1 mg 5 mg 25 mg | $62.00 $250.00 $1196.00 | ||
Chidamide is an HDAC inhibitor that leads to the accumulation of acetylated histones, including Histone cluster 1 H3B. By preventing deacetylation, it disrupts normal chromatin structure and inhibits the functional role of Histone cluster 1 H3B in gene expression regulation. | ||||||